AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767E952. A total of 3 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $94,000 | +36.2% | 31,600 | -31.5% | 0.00% | 0.0% |
| Q2 2016 | $69,000 | +213.6% | 46,100 | +668.3% | 0.00% | – |
| Q1 2016 | $22,000 | -94.2% | 6,000 | -84.0% | 0.00% | -100.0% |
| Q4 2015 | $379,000 | -68.3% | 37,500 | -57.3% | 0.00% | -76.5% |
| Q3 2015 | $1,195,000 | +43.8% | 87,900 | +100.7% | 0.02% | +41.7% |
| Q2 2015 | $831,000 | -76.6% | 43,800 | -67.7% | 0.01% | -78.6% |
| Q1 2015 | $3,546,000 | +27.1% | 135,500 | +1.7% | 0.06% | +33.3% |
| Q4 2014 | $2,791,000 | -47.6% | 133,300 | -16.4% | 0.04% | -48.8% |
| Q3 2014 | $5,324,000 | +10.3% | 159,500 | +6.1% | 0.08% | +10.8% |
| Q2 2014 | $4,826,000 | -17.8% | 150,400 | +18.1% | 0.07% | -25.3% |
| Q1 2014 | $5,871,000 | +83.9% | 127,300 | +182.9% | 0.10% | +106.2% |
| Q4 2013 | $3,193,000 | -84.7% | 45,000 | -81.5% | 0.05% | -88.0% |
| Q3 2013 | $20,836,000 | +6.8% | 243,100 | -21.1% | 0.40% | -17.0% |
| Q2 2013 | $19,509,000 | – | 308,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,370 | $15,012,000 | 1.00% |
| GROUP ONE TRADING, L.P. | 308,000 | $19,509,000 | 0.48% |
| Citadel Advisors | 32,800 | $2,078,000 | 0.00% |